Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Irena Misiewicz-Krzemińska"'
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-5 (2024)
Abstract The hematopoietic stem cell transplantation (HSCT) procedure is considered a cardiovascular burden. This is due to the potentially cardiotoxic cytostatic agents used before and the risks associated with peri-transplant procedures. We designe
Externí odkaz:
https://doaj.org/article/26b8e3f9ec55489da02b860c303e7060
Autor:
Patryk Krzemiński, Irena Misiewicz-Krzemińska, Marta Grodzik, Irena Padzińska-Pruszyńska, Paulina Kucharzewska, Agnieszka Ostrowska, Ewa Sawosz, Paweł Pomorski
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 170, Iss , Pp 116090- (2024)
Purpose: The aim of the study was to evaluate the effect of silver nanoparticles hydrocolloids (AgNPs) on human corneal epithelial cells. Epithelial cells form the outermost and the most vulnerable to environmental stimuli layer of the cornea in the
Externí odkaz:
https://doaj.org/article/dd9191428b9c42e5984bb77a7502620e
Autor:
Aleksander Salomon-Perzyński, Joanna Barankiewicz, Marcin Machnicki, Irena Misiewicz-Krzemińska, Michał Pawlak, Sylwia Radomska, Agnieszka Krzywdzińska, Aleksandra Bluszcz, Piotr Stawiński, Małgorzata Rydzanicz, Natalia Jakacka, Iwona Solarska, Katarzyna Borg, Zofia Spyra-Górny, Tomasz Szpila, Bartosz Puła, Sebastian Grosicki, Tomasz Stokłosa, Rafał Płoski, Ewa Lech-Marańda, Jana Jakubikova, Krzysztof Jamroziak
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1674 (2022)
Clonal evolution drives treatment failure in multiple myeloma (MM). Here, we used a custom 372-gene panel to track genetic changes occurring during MM progression at different stages of the disease. A tumor-only targeted next-generation DNA sequencin
Externí odkaz:
https://doaj.org/article/157b567d61334d2ca4fc78ec78d72b72
Autor:
Barbara Strojny, Sławomir Jaworski, Irena Misiewicz-Krzemińska, Isabel Isidro, Elizabeta A. Rojas, Norma C. Gutiérrez, Marta Grodzik, Piotr Koczoń, André Chwalibog, Ewa Sawosz
Publikováno v:
Materials, Vol 13, Iss 15, p 3420 (2020)
The interest around the graphene family of materials is constantly growing due to their potential application in biomedical fields. The effect of graphene and its derivatives on cells varies amongst studies depending on the cell and tissue type. Sinc
Externí odkaz:
https://doaj.org/article/80d3c50e2ffb41e2b0920c13762f8ee7
Publikováno v:
Cancers. 14(22)
Multiple myeloma (MM) is a plasma cell-derived malignancy that stands for around 1.5% of newly discovered cancer cases. Despite constantly improving treatment methods, the disease is incurable with over 13,000 deaths in the US and over 30,000 in Euro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d9251e8fe0bd7a7190826b758c3675
https://pubmed.ncbi.nlm.nih.gov/36428668
https://pubmed.ncbi.nlm.nih.gov/36428668
Autor:
Joanna, Barankiewicz, Aleksander, Salomon-Perzyński, Irena, Misiewicz-Krzemińska, Ewa, Lech-Marańda
Publikováno v:
Cancers. 14(18)
Multiple myeloma (MM) is the second most common hematological malignancy with a recurrent clinical course. The introduction of immunomodulatory drugs (IMiDs) was one of the milestones in MM therapy leading to a significant improvement in patients' pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b45732be24ee6debffa8135b01de3848
https://pubmed.ncbi.nlm.nih.gov/36139651
https://pubmed.ncbi.nlm.nih.gov/36139651
Autor:
Joanna Barankiewicz, Aleksander Salomon-Perzyński, Irena Misiewicz-Krzemińska, Ewa Lech-Marańda
Publikováno v:
Cancers. 14:4492
Multiple myeloma (MM) is the second most common hematological malignancy with a recurrent clinical course. The introduction of immunomodulatory drugs (IMiDs) was one of the milestones in MM therapy leading to a significant improvement in patients’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb1b4959c61194537936e156ef776c2e
https://doi.org/10.3390/cancers14184492
https://doi.org/10.3390/cancers14184492
Autor:
Irena Misiewicz-Krzemińska, Ewa Lech-Marańda, Aleksander Salomon-Perzyński, Monika Prochorec-Sobieszek, Joanna Barankiewicz, Agata Malenda, Filip Garbicz, Paulina Wieszczy, Anna Szumera-Ciećkiewicz, Przemyslaw Juszczynski
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 2683, p 2683 (2021)
Journal of Clinical Medicine
Volume 10
Issue 12
Journal of Clinical Medicine
Volume 10
Issue 12
Immunomodulatory drugs (IMiDs) are effective in the treatment of multiple myeloma (MM), myelodysplastic syndrome with deletion of chromosome 5q and other haematological malignancies. Recent studies showed that IMiDs bind to cereblon (CRBN), a substra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aea66833816c50d1f9b4360a7d55a27f
https://www.mdpi.com/2077-0383/10/12/2683
https://www.mdpi.com/2077-0383/10/12/2683
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Multiple myeloma is an incurable cancer that originates from antibody-producing plasma cells. It is characterized by an intrinsic ability to produce large amounts of immunoglobulin-like proteins. The high rate of synthesis makes myeloma cells depende
Externí odkaz:
https://doaj.org/article/8df778689d2f459c89dbea6af1746f26
Autor:
Ignacio J. Cardona-Benavides, Irena Misiewicz-Krzeminska, Elizabeta A. Rojas, Cristina De Ramón, Antonio Sanz-Solas, Isabel Isidro, Dalia Quwaider, Aida M. López-Guerrero, Myriam Cuadrado, María-José Calasanz, Laura Rosiñol, Joaquín Martínez-López, Jesús F. San Miguel, María-Victoria Mateos, Luis A. Corchete, Norma C. Gutiérrez
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Upregulation of a cyclin D gene determined by expression microarrays is an almost universal event in multiple myeloma (MM), but this finding has not been properly confirmed at the protein level. For this reason, we carried out a quantitative analysis
Externí odkaz:
https://doaj.org/article/d2fb4d2c2d1d4ba0898028202a445ac2